Stifel Financial
BMY.RT

Stifel Financial’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Stifel Financial’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-411,078
Closed -$283K – 3348
2020
Q4 		$283K Sell
411,078
-98,721
-19% -$210K ﹤0.01% 2619
2020
Q3 		$1.15M Sell
509,799
-22,240
-4% -$63.5K ﹤0.01% 1541
2020
Q2 		$1.9M Sell
532,039
-12,937
-2% -$46.7K ﹤0.01% 1185
2020
Q1 		$1.87M Sell
544,976
-29,313
-5% -$96.6K 0.01% 1074
2019
Q4 		$1.53M Buy
+574,289
New +$1.49M ﹤0.01% 1525

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Stifel Financial's BMY.RT Position: Q1 2021 in Review

Stifel Financial sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 411,078 shares — an estimated $283K sold.

Stifel Financial first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $1.9M in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Stifel Financial reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Stifel Financial sold 411,078 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $283K.
  • Stifel Financial first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Stifel Financial's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1.9M in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Stifel Financial's 13F filing for Q1 2021, filed 14 May 2021.